Jiangsu Aoyang Health Industryltd Valuation

Is 002172 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 002172 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 002172's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 002172's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 002172?

Key metric: As 002172 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 002172. This is calculated by dividing 002172's market cap by their current earnings.
What is 002172's PE Ratio?
PE Ratio	51.9x
Earnings	CN¥48.73m
Market Cap	CN¥2.53b

002172 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.5x
Enterprise Value/EBITDA	22.9x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 002172's PE Ratio compare to its peers?

The above table shows the PE ratio for 002172 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	28x
301059 Jinsanjiang (Zhaoqing) Silicon Material	50.9x	n/a	CN¥2.6b
002998 Elite Color Environmental Resources Science & Technology	17.4x	n/a	CN¥2.2b
603725 Guangdong Tianan New Material	16.9x	n/a	CN¥2.1b
300743 Hangzhou Todaytec Digital	26.8x	n/a	CN¥2.4b
002172 Jiangsu Aoyang Health Industryltd	51.9x	n/a	CN¥2.5b

Price-To-Earnings vs Peers: 002172 is expensive based on its Price-To-Earnings Ratio (51.9x) compared to the peer average (28.1x).

Price to Earnings Ratio vs Industry

How does 002172's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 002172 is expensive based on its Price-To-Earnings Ratio (51.9x) compared to the CN Chemicals industry average (35.9x).

Price to Earnings Ratio vs Fair Ratio

What is 002172's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

002172 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	51.9x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 002172's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Yunnan Yuntianhua

CN¥39.9b

Engages in the phosphate ore mining, chemical fertilizers, engineering materials, agriculture, and trade and logistics businesses in China.

600096

CN¥21.90

-1.7%

37.1%

Western MiningLtd

CN¥39.7b

Engages in the mining, smelting, and trading of metals in Mainland China and internationally.

601168

CN¥16.68

-4.5%

29.6%

MeiHua Holdings GroupLtd

CN¥28.8b

A synthetic biology company, provides amino acid nutrition and health solutions in China and internationally.

600873

CN¥10.10

-2.2%

7.0%